Improved Biocompatibility of Intra-Arterial Poly-L-Lactic Acid Stent by Tantalum Ion Implantation : 3-Month Results in a Swine Model

Objective Biodegradable poly-L-lactic acid (PLLA) with a highly biocompatible surface via tantalum (Ta) ion implantation can be an innovative solution for the problems associated with current biodegradable stents. The purpose of this study is to develop a Ta-implanted PLLA stent for clinical use and to investigate its biological performance capabilities. Methods A series of in vitro and in vivo tests were used to assess the biological performance of bare and Ta-implanted PLLA stents. The re-endothelialization ability and thrombogenicity were examined through in vitro endothelial cell and platelet adhesion tests. An in vivo swine model was used to evaluate the effects of Ta ion implantation on subacute restenosis and thrombosis. Angiographic and histologic evaluations were conducted at one, two and three months post-treatment. Results The Ta-implanted PLLA stent was successfully fabricated, exhibiting a smooth surface morphology and modified layer integration. After Ta ion implantation, the surface properties were more favorable for rapid endothelialization and for less platelet attachment compared to the bare PLLA stent. In an in vivo animal test, follow-up angiography showed no evidence of in-stent stenosis in either group. In a microscopic histologic examination, luminal thrombus formation was significantly suppressed in the Ta-implanted PLLA stent group according to the 2-month follow-up assessment (21.2% vs. 63.9%, p=0.005). Cells positive for CD 68, a marker for the monocyte lineage, were less frequently identified around the Ta-implanted PLLA stent in the 1-month follow-up assessments. Conclusion The use of a Ta-implanted PLLA stent appears to promote re-endothelialization and anti-thrombogenicity.

[1]  Hyoun‐Ee Kim,et al.  Enhanced Osseointegration Ability of Poly(lactic acid) via Tantalum Sputtering-Based Plasma Immersion Ion Implantation. , 2019, ACS applied materials & interfaces.

[2]  G. Stone,et al.  Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial , 2018, The Lancet.

[3]  Guixue Wang,et al.  Biodegradable stents for coronary artery disease treatment: Recent advances and future perspectives. , 2018, Materials science & engineering. C, Materials for biological applications.

[4]  Guixue Wang,et al.  Endovascular stent-induced alterations in host artery mechanical environments and their roles in stent restenosis and late thrombosis , 2018, Regenerative biomaterials.

[5]  P. Teirstein,et al.  3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial. , 2017, Journal of the American College of Cardiology.

[6]  P. Serruys,et al.  Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials , 2017, European heart journal.

[7]  Yufeng Zheng,et al.  A review on biodegradable materials for cardiovascular stent application , 2016, Frontiers of Materials Science.

[8]  E. Bolbasov,et al.  Surface modification of poly-ε-caprolactone electrospun fibrous scaffolds using plasma discharge with sputter deposition of a titanium target , 2016 .

[9]  F. Eberli,et al.  Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings. , 2015, Journal of the American College of Cardiology.

[10]  E. Bolbasov,et al.  Modification of polylactic acid surface using RF plasma discharge with sputter deposition of a hydroxyapatite target for increased biocompatibility , 2015 .

[11]  C. Hamm,et al.  Current status of bioresorbable scaffolds in the treatment of coronary artery disease. , 2014, Journal of the American College of Cardiology.

[12]  O. Kwon,et al.  Delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysm: characteristics and optimal duration of preventative dual antiplatelet therapy. , 2014, Radiology.

[13]  Y. Wang,et al.  Microstructures, mechanical behavior, cellular response, and hemocompatibility of bulk ultrafine-grained pure tantalum. , 2014, Journal of biomedical materials research. Part B, Applied biomaterials.

[14]  S. Fischer,et al.  A comparison of functional and physical properties of self-expanding intracranial stents [Neuroform3, Wingspan, Solitaire, Leo+, Enterprise]. , 2011, Minimally invasive neurosurgery : MIN.

[15]  A. Janorkar,et al.  Poly(lactic acid) modifications , 2010 .

[16]  Andrzej K. Bledzki,et al.  Mechanical properties of PLA composites with man-made cellulose and abaca fibres , 2009 .

[17]  M. Vert,et al.  Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents. , 2007, Journal of pharmaceutical sciences.

[18]  Takao Hanawa,et al.  Metal ion release from metal implants , 2004 .

[19]  N. Huang,et al.  Antithrombogenic investigation of surface energy and optical bandgap and hemocompatibility mechanism of Ti(Ta(+5))O2 thin films. , 2002, Biomaterials.

[20]  K. Toyoda,et al.  Comparative studies by cell culture and in vivo implantation test on the toxicity of natural rubber latex materials. , 1992, Journal of biomedical materials research.

[21]  R E Vlietstra,et al.  Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. , 1992, Journal of the American College of Cardiology.

[22]  C. Tarabusi,et al.  Results of histological grading on 100 cases of hip prosthesis failure. , 1988, Biomaterials.

[23]  P. Chu,et al.  Corrosion resistance and cytocompatibility of tantalum-surface-functionalized biomedical ZK60 Mg alloy , 2017 .

[24]  Nugraha Edhi Suyatma,et al.  Mechanical and Barrier Properties of Biodegradable Films Made from Chitosan and Poly (Lactic Acid) Blends , 2004 .